BETA BIONICS, INC.: latest developments and connections

What's happening

Reports per dayLast 90 days

90 days agoDrag either end to show only events that began in that periodToday

Active this week

FDA issued a Form 483 after inspecting Beta Bionics, while Josh Wilson represented investors in a class action suit.

Some support1 report

Earlier this month

Beta Bionics received FDA clearance for its iLet Bionic Pancreas device on August 21, 2025.

Some support3 reports1 development inside
FDA released a warning letter regarding device failures involving Beta Bionics, Inc.

Some support3 reports
Lawsuit filed by Beta Bionics, Inc. in the Central District of California.

Some support1 report
Beta Bionics, Inc. is accused of failing to accurately describe observations made by the FDA.

Some support5 reports1 development inside

Gone quiet

No new reports in 90+ days

Around BETA BIONICS, INC. this week

News at the entities that move BETA BIONICS, INC. most

FDA Structural
Generic medicine services are seeking approval for launch from the FDA.

Moves BETA BIONICS, INC.
Mon 17:49
SEC Structural
DHS, DOJ, and SEC formed a joint initiative to establish a Trade Fraud Task Force, setting standards for compliance.

Moves BETA BIONICS, INC.
Mon 17:57
Wells Fargo Mentioned together
Wells Fargo upgraded Sweetgreen stock to overweight from equal weight on September 28, 2026.

Moves BETA BIONICS, INC.
Mon 16:33
Josh Wilson Structural
Josh Wilson advised investors concerning Lincoln Educational Services Corporation on September 1, 2026.

Moves BETA BIONICS, INC.
Mon 00:53
Truist Financial Transactional
MarketBeat aggregates data on Inventiva's stock, and Truist Financial has started coverage of the company.

Moves BETA BIONICS, INC.
Mon 13:11
Irvine Shared context
Irvine city council planned to build a cemetery on the Orange County Great Park land.

Moves BETA BIONICS, INC.
Sun 06:21

Connections

The 9 strongest of 18, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.

FDA Structural

The FDA formally regulates Beta Bionics, overseeing its medical device products by issuing clearances, warning letters, and required documentation.

Well supportedSun 04:05

BETA BIONICS, INC. → FDA
FDA → BETA BIONICS, INC.
SEC Structural

Beta Bionics operates under the mandatory regulatory oversight and filing requirements of the U.S. Securities and Exchange Commission.

Some supportFri 10:14

BETA BIONICS, INC. → SEC
SEC → BETA BIONICS, INC.
Josh Wilson Structural

Josh Wilson serves as legal counsel representing investors in a class action lawsuit involving Beta Bionics.

Some supportFri 14:44

BETA BIONICS, INC. → Josh Wilson
Josh Wilson → BETA BIONICS, INC.
Truist Financial Transactional

Truist Financial assessed BETA Bionics, Inc. by adjusting its price targets and providing analyst coverage.

Some supportFri 10:14

BETA BIONICS, INC. → Truist Financial
Truist Financial → BETA BIONICS, INC.
Ilet Structural

BETA BIONICS manufactures the iLet Bionic Pancreas, utilizing the location Ilet for its operations.

Some supportSep 16

BETA BIONICS, INC. → Ilet
Ilet → BETA BIONICS, INC.
Wells Fargo Mentioned together

Wells Fargo provides market visibility and analyst coverage for Beta Bionics.

Some supportFri 10:14

BETA BIONICS, INC. → Wells Fargo
Wells Fargo → BETA BIONICS, INC.
Central District Shared context

BETA BIONICS, INC. filed a lawsuit within the jurisdiction of the Central District.

Some supportSep 15

BETA BIONICS, INC. → Central District
Central District → BETA BIONICS, INC.
Irvine Shared context

Beta Bionics is headquartered and reports financial results from the location of Irvine.

SpeculativeJul 30

BETA BIONICS, INC. → Irvine
Irvine → BETA BIONICS, INC.

Show all 9 connections

New York Shared context

BETA BIONICS, INC. is involved in a legal action that takes place within the jurisdiction of New York.

Some supportSep 9

BETA BIONICS, INC. → New York
New York → BETA BIONICS, INC.

History

Events by the month they began

September 2026

4 events

June 2026

3 events